Cite
MLA Citation
Bente Glintborg et al.. “To switch or not to switch: results of a nationwide guideline of mandatory switching from originator to biosimilar etanercept. One-year treatment outcomes in 2061 patients with inflammatory arthritis from the DANBIO registry.” Annals of the rheumatic diseases, vol. 78, no. 2, 2019, pp. 192–. http://access.bl.uk/ark:/81055/vdc_100130159018.0x00005a